β-arrestin2 inhibits opioid-induced breast cancer cell death through Akt and caspase-8 pathways
Neoplasma · 2009
DOI: 10.4149/neo_2009_02_108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neoplasma, 2009. Verfasst von M Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, James Quillen College of Medicine, East Tennessee State University, TN, USA. Die Arbeit wurde bisher 26-mal zitiert (Crossref). Gefördert von: NIDA NIH HHS.
Abstract (Originalsprache)
UNLABELLED: beta-arrestins, a family of regulatory and scaffold proteins, are well-known negative regulators of G-protein-coupled receptors (GPCRs) including opioid receptors. Recent studies have shown that beta-arrestin2 plays a potential role in inhibiting cell death. It has been reported that opioids such as morphine induce cell death at high concentrations (>500 microM for 24 hours), which is similar to morphine plasma concentrations in cancer patients receiving chronic morphine treatment for pain relievers. However, the role of beta-arrestin2 in opioid-induced cell death remains to be elucidated. We report here that beta-arrestin2 significantly blocks morphine-induced number of cell death in human breast cancer MCF-7 and MDA-MB231 cells. Suppression of endogenous beta-arrestin2 by specific RNA interfering (RNAi) and morphine treatment significantly attenuates the levels of phosphorylated Akt compared with inhibition of beta-arrestin2 or morphine treatment alone. However, blockade of morphine-induced cell death by beta-arrestin2 seems to be dependent on the inhibition of caspase-8, as inhibition of beta-arrestin2 and morphine treatment significantly enhanced the levels of cleaved caspase-8. These studies show for the first time that beta-arrestin2 blocks morphine-induced cell death through anti-apoptotic Akt and pro-apoptotic caspase-8 pathways. Therefore, targeting beta-arrestin2 may be useful for treating side effects of opioids as pain relievers for cancer patients. KEYWORDS: Breast cancer, beta-arrestin, opioid. Akt, caspase-8,cell death.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, James Quillen College of Medicine, East Tennessee State University, TN, USA.
Förderung
- NIDA NIH HHS
Zitieren
APA
Zhao, M., Zhou, G., Zhang, Y., Chen, T., Sun, X., Stuart, C., Hanley, G., Li, J., Zhang, J., & Yin, D. (2009). β-arrestin2 inhibits opioid-induced breast cancer cell death through Akt and caspase-8 pathways. Neoplasma. https://doi.org/10.4149/neo_2009_02_108
Vancouver
Zhao M, Zhou G, Zhang Y, Chen T, Sun X, Stuart C, et al. β-arrestin2 inhibits opioid-induced breast cancer cell death through Akt and caspase-8 pathways. Neoplasma. 2009. doi:10.4149/neo_2009_02_108
BibTeX
@article{Zhao2009,
author = {Zhao, M and Zhou, G and Zhang, Y and Chen, T and Sun, X and Stuart, C and Hanley, G and Li, J and Zhang, J and Yin, D},
title = {β-arrestin2 inhibits opioid-induced breast cancer cell death through Akt and caspase-8 pathways},
journal = {Neoplasma},
year = {2009},
doi = {10.4149/neo_2009_02_108}
}
EUVIMED